Results 241 to 250 of about 169,102 (267)

Calcifediol in Chronic Renal Insufficiency

JAMA: The Journal of the American Medical Association, 1976
To the Editor.— The reader who is not highly familiar with the recent developments concerning vitamin D and its various active forms may be misled by certain comments made (235: 164, 1976) by Teitelbaum and associates. First, the major reason for the interest in the treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol (1,25-dihydroxy ...
Anthony W. Norman, Jack W. Coburn
openaire   +5 more sources

Renal Handling of Citrate in Chronic Renal Insufficiency

Nephron, 1991
Citrate is a relevant component of the inhibitory potential of the urine environment. Its excretion and renal handling have been widely studied in subjects with normal renal function, but little is known about changes induced by chronic renal insufficiency.
Corrado Vitale, Michele Petrarulo, Caterina Martini, Marco Manganaro, Domenico Cosseddu, Franco Linari, Martino Marangella   +6 more
openaire   +3 more sources

Cardiovascular disease in chronic renal insufficiency

American Journal of Kidney Diseases, 2000
Cardiovascular illness is an important contributor to the morbidity of kidney disease. The spectrum of cardiovascular disease (CVD) in patients with chronic renal insufficiency (CRI) includes left ventricular hypertrophy (LVH) and dilatation, ischemic heart disease, and peripheral vascular disease.
Adeera Levin, Robert N. Foley
openaire   +2 more sources

Lipoprotein metabolism in chronic renal insufficiency

Pediatric Nephrology, 2007
Chronic renal insufficiency (CRI) is associated with a characteristic dyslipidemia. Findings in children with CRI largely parallel those in adults. Moderate hypertriglyceridemia, increased triglyceride-rich lipoproteins (TRL) and reduced high-density lipoproteins (HDL) are the most usual findings, whereas total and low-density lipoprotein cholesterol ...
Henry N. Ginsberg, Jeffrey M. Saland
openaire   +3 more sources

Chronic renal insufficiency (CRI) in urolithiasis

International Urology and Nephrology, 1980
In 80 adult kidney stone formers (52 with reversible and 28 with irreversible renal impairment) laboratory and clinical data were evaluated to estimate the share of abnormalities in the metabolism of stone forming substances in the development of renal impairment, and to search for the causes of the irreversibility of renal impairment.
J. Gratzlová, V. Revúsová, V. Pribylincová, J. Řezníček, E. Borošová, Z. Zvara, J Krídl   +6 more
openaire   +3 more sources

The Immunological State in Chronic Renal Insufficiency

The International Journal of Artificial Organs, 1982
To evaluate the immunological state in chronic renal insufficiency, the Authors studied cellular and humoral immunity in 292 patients with chronic renal failure. They were divided into 3 groups: 1) 37 with creatinine clearance between 50 and 20 ml/min; 2) 57 with creatinine clearance between 20 and 8 ml/min; 3) 178 treated by hemodialysis.
S Alloatti, Giraudo G, Piccoli Gb, G M Bosticardo, Giacchino F, F. Quarello   +5 more
openaire   +2 more sources

Oral cholecystography in chronic renal insufficiency

The American Journal of Digestive Diseases, 1978
Thirty-two patients with chronic renal insufficiency (CRI) had oral cholecystography. Eleven of 15 patients (73%) with moderately advanced renal impairment had diagnostically inadequate single-dose cholecystograms. In contrast, all 11 patients on chronic hemodialysis had diagnostically opacified gallbladders following a single dose of contrast.
Robert E. Koehler, Robert J. Stanley, Gary R. Zuckerman, Robert P. Perrillo   +3 more
openaire   +3 more sources

Timolol kinetics in chronic renal insufficiency

Clinical Pharmacology & Therapeutics, 1978
A single‐dose kinetic study of oral timolol, 20 mg, was undertaken in 3 groups of volunteers with varying degrees of renal function—(1) 10 normal subjects (N); (2) 9 patients with moderate chronic renal insufficiency (MCRI; Ccn 20 to 50 ml/min); (3) 4 patients with end‐stage renal disease (ESRD)—to assess the need for dosage modification as renal ...
Patricia Busby, Gaddo Onesti, Joseph M. Pitone, Melton B. Affrime, David T. Lowenthal, Charles Swartz, John Nancarrow, Kwan E. Kim, Jane Shirk   +8 more
openaire   +3 more sources

Reversible Insufficiency in Chronic Renal Disease

JAMA: The Journal of the American Medical Association, 1966
When renal function is decreased to approximately 30% of normal, further decreases, even though minor, produce major changes in the blood urea nitrogen level. In the presence of chronic renal disease such a change may precipitate uremia in a previously compensated patient. An important feature of the management of patients with chronic renal failure is
William J. Flanigan, George L. Ackerman
openaire   +3 more sources

RENAL URATE DEPOSITS IN CHRONIC RENAL INSUFFICIENCY

Acta Medica Scandinavica, 1968
Abstract Report of two cases of hyperuricaemia secondary to chronic renal insufficiency with tophi in the kidneys. Actual hyperuricaemic factors in connection with long uraemic conditions are discussed. The risk of secondary hyperuricaemia accentuating the renal damage is stressed.
openaire   +3 more sources